Congenital Hypothyroidism With Eutopic Thyroid Gland: Analysis of Clinical and Biochemical Features at Diagnosis and After Re-Evaluation
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
CONTEXT: In recent years changes in screening strategies for congenital hypothyroidism (CH) led to an increased detection of mild forms of CH, associated with eutopic thyroid gland. OBJECTIVES: We aimed to determine the clinical evolution of CH with eutopic thyroid gland and to find out prognostic factors at diagnosis and follow-up. PATIENTS AND METHODS: We retrospectively analyzed a group of 84 children with CH and eutopic thyroid gland treated at our institution. They all underwent clinical re-evaluation after the age of 3, based on thyroid function testing after l-thyroxine therapy withdrawal, thyroid ultrasonography, and (123)I scintigraphy with perchlorate discharge test. Genetic analysis was performed in selected cases. RESULTS: At re-evaluation, 34.5% of patients showed permanent hypothyroidism and needed l-thyroxine reintroduction, 27.4% had persistent hyperthyrotropinemia (TSH 5-10 mU/L), and 38.1% had transient hypothyroidism. Major risk factors for permanent CH were prematurity, first-degree familial history of goiter/nodules, thyroid hypoplasia at diagnosis, and high l-thyroxine requirements at follow-up. Iodine organification defects were found in 29.7% of patients, 30% of whom harbored DUOX2 mutations. TSH receptor gene mutations were found in 8.7% of patients with persistent thyroid dysfunction and negative perchlorate discharge test. CONCLUSIONS: Only one-third of patients with CH and eutopic thyroid gland needed to continue l-thyroxine therapy after re-evaluation. A frequent finding was the persistence of mild hyperthyrotropinemia. The evolution of CH remains difficult to predict, although different clinical features might suggest different outcomes. Mutations in the genes commonly linked to mild forms of CH were documented in a minority of cases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, factors such as prematurity (11,142,143), other congenital abnormalities (141), a family history of thyroid disease (142), abnormal thyroid morphology (thyroid hypoplasia at diagnosis) (142), TSH elevation >10 mU/L after the age of 1 year (when infants outgrow the LT4 dose), and a higher LT4 dose requirement at 1 to 3 years of age are associated with permanent CH”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease
(2003) · Thyroid · doi:10.1089/105072503321086962 · Cited by 1,212
Update of Newborn Screening and Therapy for Congenital Hypothyroidism
American Academy of Pediatrics, Rose, S. R., and the Section on Endocrinology and Committee on Genetics, American Thyroid Association, Brown, R. S., and the Public Health Committee, & Lawson Wilkins Pediatric Endocrine Society (2006) · Pediatrics · doi:10.1542/peds.2006-0915 · Cited by 798
Inactivating Mutations in the Gene for Thyroid Oxidase 2 (THOX2) and Congenital Hypothyroidism
Moreno, J. C., Bikker, H., Kempers, M. J. E., van Trotsenburg, A. S. P., Baas, F., de Vijlder, J. J. M., Vulsma, T., & Ris-Stalpers, C. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012752 · Cited by 485
Increase in congenital hypothyroidism in New York State and in the United States
Harris, K. B., & Pass, K. A. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.03.012 · Cited by 270 · cited 1×
“In particular, an increased incidence was documented in Italy (1:2200 according to the Italian National Registry of Infants with CH [3]; 1:1446 in Lombardy region [4], 1:1749 in Greece [5], 1:1660 in Massachusetts, USA [6]; 1:1415 in New York, USA [7], and 1:1077 in the United Kingdom [8]).”
BackgroundCorbetta, C., Weber, G., Cortinovis, F., Calebiro, D., Passoni, A., Vigone, M. C., Beck‐Peccoz, P., Chiumello, G., & Persani, L. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03568.x · Cited by 247 · cited 1×
“In particular, an increased incidence was documented in Italy (1:2200 according to the Italian National Registry of Infants with CH [3]; 1:1446 in Lombardy region [4], 1:1749 in Greece [5], 1:1660 in Massachusetts, USA [6]; 1:1415 in New York, USA [7], and 1:1077 in the United Kingdom [8]).”
BackgroundSelf-citationDeladoëy, J., Ruel, J., Giguère, Y., & Van Vliet, G. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1073 · Cited by 235
Grosse, S. D., & Van Vliet, G. (2011) · Archives of Disease in Childhood · doi:10.1136/adc.2010.190280 · Cited by 222
Hinton, C. F., Harris, K. B., Borgfeld, L., Drummond-Borg, M., Eaton, R., Lorey, F., Therrell, B. L., Wallace, J., & Pass, K. A. (2010) · Pediatrics · doi:10.1542/peds.2009-1975d · Cited by 207
Mengreli, C., Kanaka-Gantenbein, C., Girginoudis, P., Magiakou, M.-A., Christakopoulou, I., Giannoulia-Karantana, A., Chrousos, G. P., & Dacou-Voutetakis, C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0057 · Cited by 146 · cited 1×
“In particular, an increased incidence was documented in Italy (1:2200 according to the Italian National Registry of Infants with CH [3]; 1:1446 in Lombardy region [4], 1:1749 in Greece [5], 1:1660 in Massachusetts, USA [6]; 1:1415 in New York, USA [7], and 1:1077 in the United Kingdom [8]).”
BackgroundGaudino, R., Garel, C., Czernichow, P., & Léger, J. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02239.x · Cited by 138
Research works printed but not linked: 1
- 15. KrudeH,BlankensteinO. Treatingpatientsnotnumbers:thebenefit and burden of lowering TSH newborn screening cut-offs. Arch Dis Child . 2011;96:121-122.
Cited by
Léger, J., Olivieri, A., Donaldson, M., Torresani, T., Krude, H., van Vliet, G., Polak, M., Butler, G., & on behalf of ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE, A. T. C. H. C. C. G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1891 · Cited by 569
van Trotsenburg, P., Stoupa, A., Léger, J., Rohrer, T., Peters, C., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0333 · Cited by 469
“In contrast, factors such as prematurity (11,142,143), other congenital abnormalities (141), a family history of thyroid disease (142), abnormal thyroid morphology (thyroid hypoplasia at diagnosis) (142), TSH elevation >10 mU/L after the age of 1 year (when infants outgrow the LT4 dose), and a higher LT4 dose requirem…”
BackgroundSelf-citationTreatment with thyroid hormone
Biondi, B., & Wartofsky, L. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1083 · Cited by 259
Thyroid Disorders in Children and Adolescents: A Review
Hanley, P., Lord, K., & Bauer, A. J. (2016) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2016.0486 · Cited by 237
Léger, J., Olivieri, A., Donaldson, M., Torresani, T., Krude, H., van Vliet, G., Polak, M., Butler, G., & on behalf of ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE, A. T. C. H. C. C. G. (2014) · Hormone Research in Paediatrics · doi:10.1159/000358198 · Cited by 208
Metadata
- Authors
- Rabbiosi, S., Vigone, M. C., Cortinovis, F., Zamproni, I., Fugazzola, L., Persani, L., Corbetta, C., Chiumello, G., & Weber, G.
- Affiliations
- Vita-Salute San Raffaele University (IT)
- Department of Pediatrics (S.R., M.C.V., F.C., G.C., G.W.), 20132 Milan, Italy
- University of Milan (IT)
- Ospedale dei Bambini Vittore Buzzi (IT)
- Corresponding author
- Rabbiosi, Sarah
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-04-01
- Volume
- 98
- Issue
- 4
- Pages
- 1395-1402
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2051249595
- Cited by
- 131
- References
- 31
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 8 · 2023: 8 · 2022: 8 · 2021: 11 · 2020: 10 · 2019: 11 · 2018: 16 · 2017: 8 · 2016: 12 · 2015: 9 · 2014: 16 · 2013: 4
- FWCI
- 10.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Funders
- Regione Lombardia
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Head and Neck Anomalies
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- congenital hypothyroidism, transient hypothyroidism, permanent hypothyroidism, hyperthyrotropinemia, TSH receptor mutations, preterm birth, thyroid hypoplasia, prognostic factors, thyroid function tests, thyroid ultrasound
- MeSH terms
- Child, Child, Preschool, Congenital Hypothyroidism, Female, Follow-Up Studies, Humans, Infant, Newborn, Infant, Premature, Male, Prognosis, Retrospective Studies, Thyroid Function Tests, Thyroid Gland, Thyroxine, Ultrasonography, Cohort Studies, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.